Specifications
- Appearance
- White to off-white powder
- Water content (K.F.)
- ≤5.0%
Properties
- Solvents
- water (25mg/ml)
- Melting Point
- >300 °C (lit.)
Documentation
- Safety Data Sheet (SDS)
- CDX A0781 MSDS.pdf
Category: Reagents for Life Sciences
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Lithium potassium acetyl phosphate is an organometallic compound that is used as a phosphoryl group donor. It is commonly used in protein phosphorylation reactions. Lithium potassium acetyl phosphate is suitable as a source of acetyl phosphate. It is suitable for reducing inorganic monophosphate by-product formation by replacing inorganic oligophosphates in phosphatase-catalyzed transphosphorylation. It is a energy-rich compound for the regeneration of adenosine-5′-triphosphate, ATP, and other triphosphates. Lithium potassium acetyl phosphate is also used in research focused on energy storage. This compound is studied for its potential applications in the development of battery materials, particularly those involving lithium-ion technology. Researchers explore Lithium potassium acetyl phosphate for its electrochemical properties, such as ion conductivity and stability, which are for improving battery performance and longevity.
| Synonyms | Acetyl phosphate lithium potassium salt |
|---|---|
| Appearance | White to off-white powder |
| CAS-Number | 94249-01-1 |
| Molecular Formula | C2H3KLiO5P |
| Molecular Weight | 184.06 |
| Solvents | water (25mg/ml) |
| Melting Point | >300 °C (lit.) |
| Smiles | [Li+].[K+].CC(=O)OP([O-])([O-])=O |
| InChi Key | RLQMPLKXFIXRCV-UHFFFAOYSA-L |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and air. Store under inert gas. |
| Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Hazard statements | H314 – H361 |
| Precautionary statements | P201 – P260 – P280 – P301 + P330 + P331 – P303 + P361 + P353 – P305 + P351 + P338 + P310 |
| GHS Symbol | GHS05+GHS08 |
| Signal word | Danger |
| RIDADR | UN3261 |
| Transportation | Packing Group II |
| References | (1) W.R. Moore & A. Meister, Anal. Biochem. 161, 487 (1987), (3) D.C. Crans, et al., Meth. Enzymol. 136, 263 (1987), (4) D. Janasek, et al., Anal. Bioanal. Chem. 374, 1267 (2002), (5) S. Mukhopadhyay, et al., Bioorg. Chem. 36, 65 (2008), (6) Y.H. Liu, et al., J. Mol. Biol. 391, 149 (2009), (7) Q. Chen, et al., Bio. Protoc. 3, e970 (2013), (8) B. Yan, et al., World J. Microbiol. Biotechnol. 30, 1123 (2014), (9) E. Kinoshita-Kikuta, et al., PloS one 10, e0132598 (2015), (10) G. Tasnadi, et al., Adv. Synth. Catal. 360, 2394 (2018), (11) A. Karami, et al: Front. Aging Neurosci. 13, 704583 (2021), (12) E. Camprubi, et al., Astrobiol. 22, 981 (2022) |
| InChi | InChI=1S/C2H5O5P.K.Li/c1-2(3)7-8(4,5)6,,/h1H3,(H2,4,5,6),,/q,2*+1/p-2 |
| Quantity | 500 mg, 1 g, Bulk |
| cdx-Water content (K.F.) | ≤5.0% |
| cdx-Solubility (method) | 25 mg/ml in water, clear colourless |

4-Aminobenzamidine dihydrochloride